Highlights from ASCO20 and EHA25 Virtual: Hematology

This episode features Dr. Richard LeBlanc, Dr. Darrell White, and Dr. Julie Stakiw. This program was made possible by unrestricted sponsorship support from Amgen. Trials Discussed: 1. First-line for transplant-eligible myeloma: STaMINA & GMMG-HD6: 00:02:02 2. First-line for non-transplant-eligible (or transplant-deferred) myeloma: ENDURANCE, SWOG 1211 & TOURMALINE-MM4: 00:11:42 3. First-line for transplant and non-transplant eligible myeloma: GMMG-CONCEPT: 00:23:04 4. Relapsed refractory multiple myeloma: BOSTON, IKEMA & CC-92480: 00:29:17 5. CAR-T anti-BCMA: KarMMa, CARTITUDE-1 & EVOLVE: 00:44:10 6. TCE anti-BCMA: TECLISTAMAB Phase I & TCE 2+1 (CC-93269): 00:55:20